|By Business Wire||
|June 25, 2014 09:08 AM EDT||
Vioguard LLC (www.vioguard.com) announced that it has finalized a patent sale agreement with Microsoft Corporation (MSFT).
The agreement included the sale of two U.S. patents for sterilizing surfaces on input devices by Microsoft to Vioguard. The patents are for disinfecting surfaces such as computer keyboards, touchscreens and miscellaneous input devices. The specific terms of the agreement are confidential.
"The acquisition of these patents allows Vioguard to broaden our lead in the ultraviolet disinfection arena," said Laurance Ranta, President and Chief Executive Officer of Vioguard. “We are pleased to enter into this agreement with Microsoft.”
Vioguard's keyboard uses high power germicidal ultraviolet light, otherwise known as UV-C, at 254 nm wavelength. The keyboard uses UV-C lamps with a reflector and diffuser to distribute the light evenly. Based on published data, this level of UV-C will kill more than 99.99% of harmful microorganisms such as MRSA, mold, and other contaminants within seconds.
"Transformative technologies, such as those involved here, are made possible by a patent system that incentivizes innovation and research,” said Nick Psyhogeos, general manager, associate general counsel, IP licensing of the Innovation and Intellectual Property Group at Microsoft. “We’re pleased to sell these patents to Vioguard as they bring their UVC solution to the market."
For more information, contact Vioguard at 1-425-318-7900, or visit www.vioguard.com
Vioguard is a Kirkland, Washington based company with a mission to save lives, reduce sickness and stop the spread of pathogens by developing products in the area of infection prevention. The Company designed the world’s first FDA approved self-sanitizing keyboard for the medical industry that automatically disinfects computer keyboards in seconds through the use of ultraviolet light. Multiple studies have shown that shared computer keyboards and mice are two of the top vectors for the transmission of hospital acquired infections like MRSA. The device uses a proven technology to effectively kill 99.99% of all bacteria, viruses, fungi, and drug resistant pathogens responsible for millions of hospital-acquired infections yearly. For more information on Vioguard, please contact Laurance Ranta at 425-318-7900 ext. 8011 or visit www.vioguard.com
Kirkland, Washington based Vioguard has announced that it has finalized a patent sale agreement with Microsoft Corporation (MSFT).
Facebook: Vioguard Corp and Twitter: @Vioguard
Aug. 31, 2016 09:00 PM EDT Reads: 2,076
Aug. 31, 2016 09:00 PM EDT Reads: 372
Aug. 31, 2016 08:15 PM EDT Reads: 352
Aug. 31, 2016 07:45 PM EDT Reads: 1,968
Aug. 31, 2016 07:15 PM EDT Reads: 274
Aug. 31, 2016 07:00 PM EDT Reads: 303
Aug. 31, 2016 06:30 PM EDT Reads: 2,538
Aug. 31, 2016 06:15 PM EDT Reads: 3,633
Aug. 31, 2016 06:15 PM EDT Reads: 337
Aug. 31, 2016 06:15 PM EDT Reads: 243
Aug. 31, 2016 05:15 PM EDT Reads: 327
Aug. 31, 2016 05:00 PM EDT Reads: 891
Aug. 31, 2016 04:45 PM EDT Reads: 3,861
Aug. 31, 2016 04:15 PM EDT Reads: 1,001
Aug. 31, 2016 04:00 PM EDT Reads: 1,158